The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: risperdal consta     Quarter: 2016Q3

Total Records: 310     Number of Pages: 16

DRUGNAME PT EventCount
RISPERDAL CONSTA Type 2 diabetes mellitus 5
RISPERDAL CONSTA Weight decreased 5
RISPERDAL CONSTA Back pain 4
RISPERDAL CONSTA Chest discomfort 4
RISPERDAL CONSTA Drug ineffective 4
RISPERDAL CONSTA Epistaxis 4
RISPERDAL CONSTA Headache 4
RISPERDAL CONSTA Hyperhidrosis 4
RISPERDAL CONSTA Intentional self-injury 4
RISPERDAL CONSTA Libido decreased 4
RISPERDAL CONSTA Needle issue 4
RISPERDAL CONSTA Pain in extremity 4
RISPERDAL CONSTA Parkinsonism 4
RISPERDAL CONSTA Salivary hypersecretion 4
RISPERDAL CONSTA Abdominal discomfort 3
RISPERDAL CONSTA Adverse drug reaction 3
RISPERDAL CONSTA Angina pectoris 3
RISPERDAL CONSTA Arthralgia 3
RISPERDAL CONSTA Blood prolactin increased 3
RISPERDAL CONSTA Cough 3

Total Records: 310     Number of Pages: 16